• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Human acute leukemia. II. Acute lymphoblastic leukemia. Complex classification of acute leukemia].

作者信息

Lemez P

机构信息

Ustav hematologie a krevní transfúze, Praha.

出版信息

Sb Lek. 1990 Jan;92(1):23-32.

PMID:2330503
Abstract

Acute lymphoblastic leukaemias originate from cells committed either to T-lineage (T-ALL) or B-lineage (nonT-ALL). Leukaemic cells are classified into these lines according to the expression of lineage specific differentiation markers, which are T-cell receptors, associated with CD3 antigenic complex, for the T-line and immunoglobulins for the B-line. T-ALL seem to be one type of disease, in the B-lineage it is possible to distinguish several types of diseases according to clinical findings and immunoglobulin expression. Monoclonal antibodies directed against various surface antigens are used for diagnosis of ALL and their significance in various types of ALL is evaluated. Specificity of diagnostic markers is discussed especially from the point of the so called "mixed acute leukaemias", cells of which should differentiate in myeloid and lymphoid lines. The existence of a single one "mixed acute leukaemia" has not yet been reliably proved with the use of lineage specific differentiation markers. Present knowledge of karyotype findings in acute leukaemias classified according to specific differentiation markers is reviewed and the necessity to introduce a complex classification on this basis is stressed.

摘要

相似文献

1
[Human acute leukemia. II. Acute lymphoblastic leukemia. Complex classification of acute leukemia].
Sb Lek. 1990 Jan;92(1):23-32.
2
Significance of lineage specific differentiation markers for complex classification of acute leukemias. II. Acute lymphoblastic leukemias.
Neoplasma. 1990;37(3):267-81.
3
[Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].[单克隆抗体在儿童急性淋巴细胞白血病中的应用。I. 急性淋巴细胞白血病的免疫学分型]
Pediatr Pol. 1988 Nov;63(11):693-7.
4
Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.适用于检测急性白血病微小残留病的白血病相关标志物组合。
Neoplasma. 1993;40(5):275-81.
5
Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.淋巴母细胞淋巴瘤中CD79a(JCB117)与CD3的共表达。
J Pathol. 1998 Oct;186(2):140-3. doi: 10.1002/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y.
6
Immunophenotyping of peroxidase-negative acute leukaemias using immunoalkaline phosphatase (APAAP) method.使用免疫碱性磷酸酶(APAAP)法对过氧化物酶阴性急性白血病进行免疫表型分析。
Malays J Pathol. 1991 Dec;13(2):119-21.
7
[Acute leukemias in humans. I. Definition, etiology, and pathogenesis of acute leukemias. Classification of acute myeloid leukemia].
Sb Lek. 1989 Nov;91(11-12):368-84.
8
[The morphological and immunological classification of acute leukemias].
Duodecim. 1989;105(11):973-86.
9
Immunocytochemical markers in acute leukaemias diagnosis.急性白血病诊断中的免疫细胞化学标志物
Exp Oncol. 2010 Sep;32(3):195-9.
10
[Monoclonal antibodies in diagnosis of acute leukemias].[单克隆抗体在急性白血病诊断中的应用]
Przegl Lek. 1996;53(1):20-5.